- Home
- SLNH vs SHPH Comparison
SLNH vs SHPH Comparison
Compare SLNH & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNH
- SHPH
- Stock Information
- Founded
- SLNH 1961
- SHPH 2012
- Country
- SLNH United States
- SHPH United States
- Employees
- SLNH N/A
- SHPH N/A
- Industry
- SLNH EDP Services
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- SLNH Technology
- SHPH Health Care
- Exchange
- SLNH Nasdaq
- SHPH Nasdaq
- Market Cap
- SLNH 19.3M
- SHPH 3.3M
- IPO Year
- SLNH N/A
- SHPH 2022
- Fundamental
- Price
- SLNH $4.52
- SHPH $1.41
- Analyst Decision
- SLNH
- SHPH
- Analyst Count
- SLNH 0
- SHPH 0
- Target Price
- SLNH N/A
- SHPH N/A
- AVG Volume (30 Days)
- SLNH 169.6K
- SHPH 43.1K
- Earning Date
- SLNH 11-13-2024
- SHPH 11-12-2024
- Dividend Yield
- SLNH N/A
- SHPH N/A
- EPS Growth
- SLNH N/A
- SHPH N/A
- EPS
- SLNH N/A
- SHPH N/A
- Revenue
- SLNH $38,140,000.00
- SHPH N/A
- Revenue This Year
- SLNH N/A
- SHPH N/A
- Revenue Next Year
- SLNH N/A
- SHPH N/A
- P/E Ratio
- SLNH N/A
- SHPH N/A
- Revenue Growth
- SLNH 142.85
- SHPH N/A
- 52 Week Low
- SLNH $1.40
- SHPH $1.03
- 52 Week High
- SLNH $8.80
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- SLNH 67.09
- SHPH 49.84
- Support Level
- SLNH $3.17
- SHPH $1.12
- Resistance Level
- SLNH $4.25
- SHPH $1.26
- Average True Range (ATR)
- SLNH 0.40
- SHPH 0.11
- MACD
- SLNH 0.18
- SHPH 0.06
- Stochastic Oscillator
- SLNH 95.56
- SHPH 68.09
About SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.